Rising Number of Testing Facilities Is Developing the Global Cannabis Testing Market to $ 2112 by 2025

According to a new market research report published by Inkwood Research, The global artificial intelligence in healthcare market was valued at $1210 million in 2016 and is estimated to generate a net revenue of approximately $25.1 billion by 2025 growing at a CAGR of 40.07% during the forecast period 2017-2025.

According to a new market research report published by Inkwood Research, The Cannabis testing market is anticipated to grow from $ 809 million in 2016 to $ 2112 million by 2025, at a CAGR of 11.4% between 2016 and 2025

Browse 34 market data Tables and 46 Figures spread through 222 Pages and in-depth TOC on “Cannabis Testing Market Forecast 2017-2025.”

Recognition of marijuana for medical and therapeutic use by the medical fraternity, rising number of testing facilities, increasing legalization on the cannabis usage for medicine and research, rising awareness about cannabis benefits aided by a strong community support are boosting the growth of Cannabis testing market amid the globe.

Legalization of Cannabis for medical use

The legalization of Cannabis-based medicine in many countries such as Canada, Belgium, Austria, Chile, and Israel have led treatment of diseases such as Anorexia and cachexia in HIV/ Aids, vomiting and nausea associated with cancer and chronic diseases by Medical Cannabis or cannabinoids which is a medical drug. Marijuana can be good medicine to alleviate side effects of many medical conditions. The thing that makes marijuana medicine more acceptable is the fact that its side effects are mild and more manageable in comparison to conventional medicine that other practitioners use.

Terpene is the key aromatic constituent of Cannabis

Terpenes is used to identify the presence of impurities while performing cannabis testing. The detailed analysis of terpene profiling is crucial for ensuring the medical efficacy and strain identity while performing cannabis testing. Cannabis testing through detailed terpene profiling is implemented by deploying Gas Chromatography (GC) for successful treatment of multiple sclerosis conditions among patients.

Cannabis testing market in the United States is developing at a rapid pace

The United States cannabis testing market is expanding at a significant pace. The government in the U.S has legalized the usage of cannabis considering the medical research and treatment. The use of marijuana has been approved in the year 2016 by 25 states in The United States Of America. It is mainly used in the treatment of numerous chronic diseases which includes cancer, aids, and epilepsy which is a neurological condition mostly occurred in children’s and infants. The enhancing awareness of cannabis utility in the medical treatment has been an integral factor in the growth of cannabis testing in the United States.

The predominant companies in the global Cannabis testing market are Thermo Fischer Scientific, Shimadzu Corp, Agilent technologies, Waters Corp, and Steep hill halent laboratories Inc.

The cannabis testing market report provides competitive landscapes, market drivers, trends, restraints, opportunities and challenges in this market. The report estimates the current size and the future growth potential of the market across diverse applications, technologies, verticals, types, and regions.  The outlook of the report additionally comprises of mergers and acquisitions, strategies, product portfolios, agreements, partnerships and collaborations amongst the key players.

About Inkwood Research

Inkwood Research specializes in syndicated & customized research reports and consulting services.
Market intelligence studies with relevant fact-based research are customized across industry verticals including technology, automotive, chemicals, materials, healthcare, and energy with real comprehension acknowledging the business environments. Our geographical analysis comprises of North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.

Contact Us:
Inkwood Research
Tel : +1 857-302-4704